John Kline
Analyst · Hovde
Thanks, Rob. We are pleased to report that overall conditions in the direct lending market continued to be very healthy. Companies within most industries have very good access to capital and new sponsor-backed purchases are generally occurring at very healthy multiples across many industries. Companies within many of our core defensive growth sectors such as software, healthcare technology, field services and technology enabled business services have compelling momentum in their businesses and are attracting record purchase multiples from a diverse group of brand names sponsors. Interest spreads on first lien and unitranche loans have returned to pre-COVID levels while second lien spreads are modestly tighter levels observed in early 2020. Despite this modest spread pressure in the second lien market returns on new loans remain attractive both on an absolute basis and relative to other credit markets that we see. Turning to Page 15, we show how potential changes in the base rate could impact NMFCs future earnings. As you can see, the vast majority of our assets are floating-rate loans while our liabilities are 57% fixed rate and 43% floating rate. NMFC's current balance sheet mix offers our shareholders consistent and stable earnings in all scenarios where LIBOR remains under 1%. If base rates rise above 1% as the economy normalizes or accelerates there is meaningful upside to NMFC's net investment income. For example, assuming our current investment portfolio and existing liability structure if LIBOR reaches 2%, our annual NII would increase by 9.1% or $0.11 per share. At 3% LIBOR earnings would increased by 20% or $0.24 per share. Page 16 addresses historical credit performance, which shows NMFC's long term track record. On the left side of the page, we show the current state of the portfolio where we have $3 billion of investments at fair value with $25 million or less than 1% of our portfolio currently on non-accrual. This quarter, as mentioned earlier, we did not place any new borrowers on non-accrual. On the right side of the page, we present NMFCs cumulative credit performance since our inception in 2008, which shows that across $8.3 billion of total investments. We have $600 million that have been placed on our watch list with $236 million of that amount migrating to non-accrual. Of the non-accruals only $79 million, have become realized losses over the course of our 12 plus year history. Page 17 is a view of our credit performance based on underlying portfolio companies leverage relative to LTM EBITDA. As you can see the majority of our positions have shown results that are very consistent with our underwriting projections, exhibiting either very minor leverage increases or in many cases leverage decreases. We believe the strong and consistent performance across our portfolio is particularly notable in a year affected by global health crisis. On the lower right side of the page we show a group of companies, which exclude the previously restructured benefits in Permian that have more than 2.5 turns of negative leverage drift. These companies represent a small portion of our portfolio that have underperformed partially due to adverse conditions caused by the shutdown of certain parts of the economy. From a liquidity perspective, we believe that all seven companies have adequate resources to pursue their post-COVID business plans, which all contemplate higher profits compared to those of the past 12 months. Five of the companies have shown positive revenue and earnings momentum in the early months of 2021, which is not yet represented in the LTM calculations shown on Page 17. Two of the seven companies will require continued reopening of the economy to meet their medium-term financial targets. The first of these companies has material exposure to the travel industry and the other depends on revenues from in-person high school and college graduation ceremonies. On the chart on Page 18 tracks the company's overall economic performance since its IPO. At the top of the page, we show that our net investment income has always cumulatively covered our regular quarterly dividend on the lower half of the page, we focus on. below the line items where we show that since inception highlighted in the blue box NMFC has experienced $20 million of net realized losses, and in gray we show that NMFC has total unrealized portfolio markdowns of $65 million. Combined, these two numbers represent $85 million of cumulative net realized and unrealized losses. This bottom line number represents a $23 million improvement compared to last quarter driven by the positive change in our portfolio marks that we discussed in detail earlier in the presentation. Since the Q1 2020 low point in NMFC's fair value we have recovered $168 million of unrealized losses. As Rob discussed, we continue to believe that most of the remaining cumulative net unrealized loss can be recovered over time if certain performing positions return to par. Historically troubled names continue to recover and the overall value of our equity positions appreciate modestly. Page 19 shows a stock chart detailing NMFC's equity returns since IPO. While the performance of our stock was impacted by fears around the pandemic recently we have seen material improvement in our share price as investors have become comfortable with the trajectory of the US economy and gain confidence in the stability, attractive yield and upside of our portfolio. Since our IPO nearly 10 years ago NMFC has a compounded annual return of 10.3% which materially exceeds that of the high-yield index as well as an index of BDC peers that have been public at least as long as we have. Page 20 provides a final look at NMFC's cumulative return compared to the individual returns of our peers. As you can see NMFC has been the second best performer amongst the peer group that we have tracked since the IPO. We continue to build this on this total return performance with our $0.30 per share dividend, which is based on the current stock price represents an annualized dividend yield of approximately 9.1%. Turning to our investment activity tracker on Page 21, this quarter our total originations were $219 million highlighted by five new sponsor-backed club deals, the expansion of our net lease REIT and the continued investment in the SLP III joint venture. These new investments were offset by $196 million of loan repayments and sales yielding $23 million of net originations. This balanced activity is reflective of continuing to operate well within the range of our new leverage guidance. Page 22 details a group of new investments that we have made so far this quarter, which included several new club deal financings, size to accommodate our balance sheet availability. It is worth noting that we do have a long list of companies on our repayment watch list, which we believe could be exiting our portfolio in the next quarter. These loan repayments would represent a material source of cash for new deals. Turning to Page 23, as shown on the left side of the page, our origination mix by asset type in Q1 was heavily oriented towards senior assets including first-lien loans, SLP investments and net lease real estate investments. Overall these senior oriented assets represented 67% of our total new deal flow in the quarter. Repayments were weighted approximately 60% towards first lien assets and 40% towards second lien assets resulting in the current portfolio of mix shown on the right side of the page, which remains heavily weighted towards senior and secured assets. On Page 24, we show the average yield of NMFC's portfolio was stable from Q4 to Q1 at approximately 8.8%. For the quarter, we were able to originate a group of assets with a weighted average yield of 8.7%, which is roughly consistent with the portfolio average. As we mentioned earlier, while the current environment is competitive, the available spreads in the marketplace remain supportive of our NII targets. On Page 25, we have detailed breakouts of NMFC's industry exposure. The center pie chart shows overall industry exposure while the surrounding pie charts give more insight into the very significant diversity within our healthcare software and services portfolio. As you can see, we have successfully avoided nearly all of the most troubled sectors while maintaining high exposure to the most defensive sectors within the US economy. Finally, as illustrated on Page 26, we have a diversified portfolio with our largest single name investment at 3.9% of fair value in the top 15 investments accounting for 37% of fair value. And with that I will now turn it over to our CFO, Shiraz Kajee to discuss the financial statements and key financial metrics. Shiraz?